About Norlase
Norlase is a company based in Ballerup (Denmark) founded in 2014 by Oliver Hvidt. Norlase has raised $11 million across 14 funding rounds from investors including European Investment Bank, European Union and West Hill Capital. The company has 31 employees as of December 31, 2022. Norlase offers products and services including LYNX, ECHO, LION, and LEAF. Norlase operates in a competitive market with competitors including GME Medical Engineering, Energist, Global Photon, SpectraVet and Medical laser, among others.
- Headquarter Ballerup, Denmark
- Employees 31 as on 31 Dec, 2022
- Founders Oliver Hvidt
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Norlase Aps
-
Annual Revenue
$678.15 (USD)1387as on Dec 31, 2017
-
Net Profit
-$4.63 M (USD)-35as on Dec 31, 2022
-
EBITDA
-$4.99 M (USD)-35as on Dec 31, 2022
-
Total Equity Funding
$11 M (USD)
in 14 rounds
-
Latest Funding Round
$20.9 M (USD), Debt – Conventional
Mar 04, 2025
-
Investors
European Investment Bank
& 3 more
-
Employee Count
31
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Norlase
Norlase offers a comprehensive portfolio of products and services, including LYNX, ECHO, LION, and LEAF.
Portable device for pattern scanning laser eye treatments.
Compact system combining laser engine with MEMS technology for portability.
Battery-powered device with wireless interface for flexible eye treatments.
Attachable system for slit lamps without external fibers or carts.
People of Norlase
Unlock access to complete
Funding Insights of Norlase
Norlase has successfully raised a total of $11M across 14 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20.9 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Norlase
Norlase has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, European Union and West Hill Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Growth-stage venture capital investments are provided by West Hill Capital.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Norlase
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Norlase
Investment portfolio details for Norlase
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Norlase
Detailed financials for Norlase
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Norlase Comparisons
Peer comparison for Norlase
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Norlase
Norlase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GME Medical Engineering, Energist, Global Photon, SpectraVet and Medical laser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Dermatological laser and light systems are developed and marketed.
|
|
| Locked | Locked | Locked |
Light and laser systems for aesthetic medical procedures are developed.
|
|
| Locked | Locked | Locked |
Develops phototherapy devices designed for chemotherapy patients.
|
|
| Locked | Locked | Locked |
Provides advanced low-level laser therapy systems for treating musculoskeletal injuries in animals.
|
|
| Locked | Locked | Locked |
Provides laser-based devices specialized for dermal treatments.
|
Detailed competitors of Norlase
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Norlase
Complete news archive for Norlase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Norlase
Norlase was founded in 2014.
Norlase is headquartered in Ballerup, Denmark.
Oliver Hvidt is the current CEO of Norlase. They have also founded this company.
Norlase is a funded company, having raised a total of $11M across 14 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Norlase is 31.
Annual revenue of Norlase is $678.15 as on Dec 31, 2017.
Norlase was founded in 2014 in Ballerup, Denmark, as a provider of low-level laser therapy systems within the ophthalmology sector. Green laser solutions have been developed for treating retina and glaucoma diseases. The product portfolio includes indirect ophthalmoscopes integrated with green laser sources, along with green laser photocoagulators. Operations focus on medical device innovation for eye care applications.
Norlase's top competitors include GME Medical Engineering, Energist and Global Photon.
Norlase offers LYNX, ECHO, LION, and LEAF.
Norlase has 4 investors. Key investors include European Investment Bank, European Union, West Hill Capital, and EIC Fund.